FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kim Kramer

Research Profile

Disorders

Living Beings

Infants

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Brian H Kushner; Shakeel Modak; Stephen S Roberts; Ellen M Basu; Kim Kramer; Nai-Kong V Cheung
Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature.
Nai-Kong V Cheung; Kim Kramer; Brian H Kushner; Elizabeth Chamberlain; Irene Y Cheung; Irina Ostrovnaya; Shakeel Modak
Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission.
Brian H Kushner; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Successful multifold dose escalation of anti-GD2 monoclonal antibody 3F8 in patients with neuroblastoma: a phase I study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kim Kramer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Brian H Kushner; Shakeel Modak; Stephen S Roberts; Ellen M Basu; Kim Kramer; Nai-Kong V Cheung
Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature.
Cancer 2013;119(3):665-71.
2012: Nai-Kong V Cheung; Kim Kramer; Brian H Kushner; Elizabeth Chamberlain; Irene Y Cheung; Irina Ostrovnaya; Shakeel Modak
Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(26):3264-70.
2011: Brian H Kushner; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Successful multifold dose escalation of anti-GD2 monoclonal antibody 3F8 in patients with neuroblastoma: a phase I study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(9):1168-74.
2011: Richard K G Do; Sara D Shaylor; Jinru Shia; Amy Wang; Kim Kramer; Sara J Abramson; Anita P Price; Lawrence H Schwartz
Variable MR imaging appearances of focal nodular hyperplasia in pediatric cancer patients.
Pediatric radiology 2011;41(3):335-40.
2011: Brian H Kushner; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
High-dose carboplatin-irinotecan-temozolomide: treatment option for neuroblastoma resistant to topotecan.
Pediatric blood & cancer 2011;56(3):403-8.
2011: Ping He; Kim Kramer; Peter Smith-Jones; Pat Zanzonico; John L Humm; Steven M Larson; Nai-Kong V Cheung
Two-compartment model of radioimmunotherapy delivered through cerebrospinal fluid.
European journal of nuclear medicine and molecular imaging 2011;38(2):334-42.
2011: Brian H Kushner; Kim Kramer; Shakeel Modak; Karima Yataghene; Nai-Kong V Cheung
High-dose cyclophosphamide-irinotecan-vincristine for primary refractory neuroblastoma.
European journal of cancer (Oxford, England : 1990) 2011;47(1):84-9.
2010: Victoria J Croog; Kim Kramer; Nai-Kong V Cheung; Brian H Kushner; Shakeel Modak; Mark M Souweidane; Suzanne L Wolden
Whole neuraxis irradiation to address central nervous system relapse in high-risk neuroblastoma.
International journal of radiation oncology, biology, physics 2010;78(3):849-54.
2010: Mark L Kayton; Edward G Garmey; Nicole M Ishill; Nai-Kong V Cheung; Brian H Kushner; Kim Kramer; Shakeel Modak; Carol Rossetto; Courtney Hennelly; Melissa Parra Doyle; Shoshana Rosenberg; Olga Santoro; Michael P LaQuaglia
Preliminary results of a phase I trial of prophylactic ethanol-lock administration to prevent mediport catheter-related bloodstream infections.
Journal of pediatric surgery 2010;45(10):1961-6.
2010: Sonal Bhandari; Nai-Kong V Cheung; Brian H Kushner; Kim Kramer; Shakeel Modak; Steven M Larson; Samuel Yeh; Glenn Heller; Charles A Sklar
Hypothyroidism after 131I-monoclonal antibody treatment of neuroblastoma.
Pediatric blood & cancer 2010;55(1):76-80.
2010: Brian H Kushner; Kim Kramer; Shakeel Modak; Li-Xuan Qin; Nai-Kong V Cheung
Differential impact of high-dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistant neuroblastoma.
Cancer 2010;116(12):3054-60.
2010: Kim Kramer; Brian H Kushner; Shakeel Modak; Neeta Pandit-Taskar; Peter Smith-Jones; Pat Zanzonico; John L Humm; Hong Xu; Suzanne L Wolden; Mark M Souweidane; Steven M Larson; Nai-Kong V Cheung
Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma.
Journal of neuro-oncology 2010;97(3):409-18.
2009: Brian H Kushner; Kim Kramer; Shakeel Modak; Timothy Akhurst; Nai-Kong V Cheung
A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy.
Pediatric blood & cancer 2009;53(7):1340-2.
2009: Brian H Kushner; Nai-Kong V Cheung; Christopher Barker; Kim Kramer; Shakeel Modak; Karima Yataghene; Suzanne L Wolden
Hyperfractionated low-dose (21 Gy) radiotherapy for cranial skeletal metastases in patients with high-risk neuroblastoma.
International journal of radiation oncology, biology, physics 2009;75(4):1181-6.
2009: Brian H Kushner; Kim Kramer; Shakeel Modak; Li-Xuan Qin; Karima Yataghena; Suresh C Jhanwar; Nai-Kong V Cheung
Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma.
Pediatric blood & cancer 2009;53(1):17-22.
2009: Brian H Kushner; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(7):1041-6.
2009: Oren Josh Becher; Mark M Souweidane; Ehud Lavi; Kim Kramer; Eric Lis; Ashfaq Marghoob; Yasmin Khakoo
Large congenital melanotic nevi in an extremity with neurocutaneous melanocytosis.
Pediatric dermatology 2009;26(1):79-82.
2009: Shakeel Modak; Brian H Kushner; Michael P LaQuaglia; Kim Kramer; Nai-Kong V Cheung
Management and outcome of stage 3 neuroblastoma.
European journal of cancer (Oxford, England : 1990) 2009;45(1):90-8.
2008: Brian H Kushner; Michael P LaQuaglia; William L Gerald; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Solitary relapse of desmoplastic small round cell tumor detected by positron emission tomography/computed tomography.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4995-6.
2008: Brian H Kushner; Michael P LaQuaglia; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Recurrent metastatic neuroblastoma followed by myelodysplastic syndrome: possible leukemogenic role of temozolomide.
Pediatric blood & cancer 2008;51(4):552-4.
2008: Shakeel Modak; Neeta Pandit-Taskar; Brian H Kushner; Kim Kramer; Peter Smith-Jones; Steven M Larson; Nai-Kong V Cheung
Transient sialoadenitis: a complication of 131I-metaiodobenzylguanidine therapy.
Pediatric blood & cancer 2008;50(6):1271-3.
2008: Suzanne L Wolden; Christopher Barker; Brian H Kushner; Haritha Bodduluri; Cesar Della Biancia; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Brain-sparing radiotherapy for neuroblastoma skull metastases.
Pediatric blood & cancer 2008;50(6):1163-8.
2007: Kim Kramer; John L Humm; Mark M Souweidane; Pat Zanzonico; Ira J Dunkel; William L Gerald; Yasmin Khakoo; Samuel D J Yeh; Henry W D Yeung; Ronald D Finn; Suzanne L Wolden; Steven M Larson; Nai-Kong V Cheung
Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(34):5465-70.
2007: Stephen W Gilheeney; David Lyden; Shirley Sgouros; Nuno Lobo Antunes; William Gerald; Kim Kramer; Eric Lis; Paul A Meyers; Nancy Rosen; Howard T Thaler; Tanya M Trippett; Leonard H Wexler; Ira J Dunkel
A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignancies.
Pediatric blood & cancer 2007;49(3):261-5.
2007: Brian H Kushner; Irene Y Cheung; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.
Pediatric blood & cancer 2007;48(4):430-4.
2006: Brian H Kushner; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Irinotecan plus temozolomide for relapsed or refractory neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(33):5271-6.
2006: Brian H Kushner; Amy Budnick; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma.
Cancer 2006;107(2):417-22.
2006: Brian H Kushner; Kim Kramer; Michael P LaQuaglia; Shakeel Modak; Nai-Kong V Cheung
Liver involvement in neuroblastoma: the Memorial Sloan-Kettering Experience supports treatment reduction in young patients.
Pediatric blood & cancer 2006;46(3):278-84.
2006: Brian H Kushner; Kim Kramer; Shakeel Modak; Nancy A Kernan; Lilian Reich; K Danis; Nai-Kong V Cheung
Topotecan, thiotepa, and carboplatin for neuroblastoma: failure to prevent relapse in the central nervous system.
Bone marrow transplantation 2006;37(3):271-6.
2005: Bruno De Bernardi; Walentyna Balwierz; Joanna Bejent; Susan Cohn; Maria Luisa Garrè; Tomoko Iehara; Dominique Plantaz; Thorsten Simon; Paola Angelini; Armando Cama; Wendy B London; Kim Kramer; Howard M Katzenstein; Paolo Tortori-Donati; Andrea Rossi; Giulio J D'Angio; Audrey E Evans
Epidural compression in neuroblastoma: Diagnostic and therapeutic aspects.
Cancer letters 2005;228(1-2):283-99.
2005: Caroline Laverdière; Nai-Kong V Cheung; Brian H Kushner; Kim Kramer; Shakeel Modak; Michael P LaQuaglia; Suzanne L Wolden; Kirsten K Ness; James G Gurney; Charles A Sklar
Long-term complications in survivors of advanced stage neuroblastoma.
Pediatric blood & cancer 2005;45(3):324-32.
2005: James B Bussel; Stergios Zacharoulis; Kim Kramer; Janice G McFarland; Joanne Pauliny; Cécile Kaplan
Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia.
Pediatric blood & cancer 2005;45(2):176-83.
2005: Brian H Kushner; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Five-day courses of irinotecan as palliative therapy for patients with neuroblastoma.
Cancer 2005;103(4):858-62.
2004: Brian H Kushner; Kim Kramer; Michael P LaQuaglia; Shakeel Modak; Karima Yataghene; Nai-Kong V Cheung
Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(24):4888-92.
2004: Kim Kramer; Brian H Kushner; Jeffrey C Allen; George Krol; Nai-Kong V Cheung
Favorable-biology neuroblastoma presenting with leptomeningeal metastases?: a case presentation.
Journal of pediatric hematology/oncology 2004;26(11):703-5.
2004: Miederer Matthias; Michael R McDevitt; Paul E Borchardt; Ira Bergman; Kim Kramer; Nai-Kong V Cheung; David A Scheinberg
Treatment of neuroblastoma meningeal carcinomatosis with intrathecal application of alpha-emitting atomic nanogenerators targeting disialo-ganglioside GD2.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(20):6985-92.
2004: Michael P LaQuaglia; Brian H Kushner; Wendy Su; Glenn Heller; Kim Kramer; Sara Abramson; Nancy Rosen; Suzanne L Wolden; Nai-Kong V Cheung
The impact of gross total resection on local control and survival in high-risk neuroblastoma.
Journal of pediatric surgery 2004;39(3):412-7; discussion 412-7.
2004: Miederer Matthias; Michael R McDevitt; George Sgouros; Kim Kramer; Nai-Kong V Cheung; David A Scheinberg
Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primates.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(1):129-37.
2004: Brian H Kushner; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Camptothecin analogs (irinotecan or topotecan) plus high-dose cyclophosphamide as preparative regimens for antibody-based immunotherapy in resistant neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(1 Pt 1):84-7.
2004: Brian H Kushner; Michael P LaQuaglia; Kim Kramer; Nai-Kong V Cheung
Radically different treatment recommendations for newly diagnosed neuroblastoma: pitfalls in assessment of risk.
Journal of pediatric hematology/oncology 2004;26(1):35-9.
2003: David I Sandberg; Mark H Bilsky; Brian H Kushner; Mark M Souweidane; Kim Kramer; Michael P LaQuaglia; Katherine S Panageas; Nai-Kong V Cheung
Treatment of spinal involvement in neuroblastoma patients.
Pediatric neurosurgery 2003;39(6):291-8.
2003: Brian H Kushner; Kim Kramer; Michael P LaQuaglia; Shakeel Modak; Nai-Kong V Cheung
Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience.
Medical and pediatric oncology 2003;41(6):508-15.
2003: Kim Kramer; Brian H Kushner; Nai-Kong V Cheung
Oral topotecan for refractory and relapsed neuroblastoma: a retrospective analysis.
Journal of pediatric hematology/oncology 2003;25(8):601-5.
2003: Brian H Kushner; Kim Kramer; Michael P LaQuaglia; Nai-Kong V Cheung
Curability of recurrent disseminated disease after surgery alone for local-regional neuroblastoma using intensive chemotherapy and anti-G(D2) immunotherapy.
Journal of pediatric hematology/oncology 2003;25(7):515-9.
2003: Irene Y Cheung; M Serena Lo Piccolo; Brian H Kushner; Kim Kramer; Nai-Kong V Cheung
Quantitation of GD2 synthase mRNA by real-time reverse transcriptase polymerase chain reaction: clinical utility in evaluating adjuvant therapy in neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(6):1087-93.
2003: Brian H Kushner; Samuel D J Yeh; Kim Kramer; Steven M Larson; Nai-Kong V Cheung
Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(6):1082-6.
2002: Brian H Kushner; Kim Kramer; Nai-Kong V Cheung
Chronic neuroblastoma.
Cancer 2002;95(6):1366-75.
2001: Brian H Kushner; Kim Kramer; Nai-Kong V Cheung
Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(22):4189-94.
2001: Nai-Kong V Cheung; Brian H Kushner; Kim Kramer
Monoclonal antibody-based therapy of neuroblastoma.
Hematology/oncology clinics of North America 2001;15(5):853-66.
2001: Brian H Kushner; Nai-Kong V Cheung; Kim Kramer; Ira J Dunkel; Elizabeth Calleja; Farid Boulad
Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults.
Bone marrow transplantation 2001;28(6):551-6.
2001: Brian H Kushner; Henry W D Yeung; Steven M Larson; Kim Kramer; Nai-Kong V Cheung
Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(14):3397-405.
2001: Brian H Kushner; Suzanne L Wolden; Michael P LaQuaglia; Kim Kramer; David Verbel; Glenn Heller; Nai-Kong V Cheung
Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(11):2821-8.
2001: Shakeel Modak; Kim Kramer; Sakir Humayun Gultekin; Hong-Fen Guo; Nai-Kong V Cheung
Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors.
Cancer research 2001;61(10):4048-54.
2001: Kim Kramer; Brian H Kushner; Glenn Heller; Nai-Kong V Cheung
Neuroblastoma metastatic to the central nervous system. The Memorial Sloan-kettering Cancer Center Experience and A Literature Review.
Cancer 2001;91(8):1510-9.
2001: Kim Kramer; Nai-Kong V Cheung
Antibody-based diagnostic and therapeutic innovations for human cancer.
Comprehensive therapy 2001;27(3):183-94.
2001: Nai-Kong V Cheung; Brian H Kushner; Michael P LaQuaglia; Kim Kramer; SV Gollamudi; Glenn Heller; William Gerald; S Yeh; Ronald Finn; Steven M Larson; David Wuest; M Byrnes; E Dantis; Jaume Mora; Irene Y Cheung; NS Rosenfield; Sara Abramson; Richard J O'Reilly
N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.
Medical and pediatric oncology 2001;36(1):227-30.
2001: Kim Kramer; William L Gerald; Brian H Kushner; Steven M Larson; Meera Hameed; Nai-Kong V Cheung
Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma.
Medical and pediatric oncology 2001;36(1):194-6.
2000: Kim Kramer; Nai-Kong V Cheung; John L Humm; E Dantis; Ronald Finn; S J Yeh; Nuno Lobo Antunes; Ira J Dunkel; M Souwedaine; Steven M Larson
Targeted radioimmunotherapy for leptomeningeal cancer using (131)I-3F8.
Medical and pediatric oncology 2000;35(6):716-8.
2000: Brian H Kushner; Glenn Heller; Kim Kramer; Nai-Kong V Cheung
Granulocyte-colony stimulating factor and multiple cycles of strongly myelosuppressive alkylator-based combination chemotherapy in children with neuroblastoma.
Cancer 2000;89(10):2122-30.
2000: Brian H Kushner; Kim Kramer; Paul A Meyers; Norma Wollner; Nai-Kong V Cheung
Pilot study of topotecan and high-dose cyclophosphamide for resistant pediatric solid tumors.
Medical and pediatric oncology 2000;35(5):468-74.
2000: Suzanne L Wolden; SV Gollamudi; Brian H Kushner; Michael P LaQuaglia; Kim Kramer; Nancy Rosen; Sara Abramson; Nai-Kong V Cheung
Local control with multimodality therapy for stage 4 neuroblastoma.
International journal of radiation oncology, biology, physics 2000;46(4):969-74.
2000: J Mora; Nai-Kong V Cheung; Brian H Kushner; Michael P LaQuaglia; Kim Kramer; Melissa Fazzari; Glenn Heller; L Chen; W L Gerald
Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p.
The Journal of molecular diagnostics : JMD 2000;2(1):37-46.
1999: Brian H Kushner; Michael P LaQuaglia; Nai-Kong V Cheung; Kim Kramer; AC Hamelin; William L Gerald; Marc Ladanyi
Clinically critical impact of molecular genetic studies in pediatric solid tumors.
Medical and pediatric oncology 1999;33(6):530-5.
1999: Brian H Kushner; Kim Kramer; Nai-Kong V Cheung
Oral etoposide for refractory and relapsed neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3221-5.
1999: Peter Cole; Marc Ladanyi; William L Gerald; Nai-Kong V Cheung; Kim Kramer; Michael P LaQuaglia; Brian H Kushner
Synovial sarcoma mimicking desmoplastic small round-cell tumor: critical role for molecular diagnosis.
Medical and pediatric oncology 1999;32(2):97-101.
1999: Nai-Kong V Cheung; Glenn Heller; Brian H Kushner; Kim Kramer
Detection of neuroblastoma in bone marrow by immunocytology: is a single marrow aspirate adequate?
Medical and pediatric oncology 1999;32(2):84-7.
1998: Brian H Kushner; Nai-Kong V Cheung; Kim Kramer; Glenn Heller; Suresh C Jhanwar
Neuroblastoma and treatment-related myelodysplasia/leukemia: the Memorial Sloan-Kettering experience and a literature review.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(12):3880-9.
1998: Kim Kramer; William L Gerald; Brian H Kushner; Steven M Larson; Meera Hameed; Nai-Kong V Cheung
Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(9):2135-9.
1998: Nai-Kong V Cheung; Brian H Kushner; Irene Y Cheung; Kim Kramer; A Canete; William Gerald; M A Bonilla; Ronald Finn; S J Yeh; Steven M Larson
Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):3053-60.
1998: Brian H Kushner; Glenn Heller; Nai-Kong V Cheung; Norma Wollner; Kim Kramer; Dean F Bajorin; Tatyana Polyak; Paul A Meyers
High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):3016-20.
1997: Kim Kramer; Nai-Kong V Cheung; John L Humm; Gene R DiResta; E Arbit; Steven M Larson; Ronald Finn; Marc K Rosenblum; H Nguyen; G Gonzalez; C Liu; Y F Yang; M E Mendelsohn; AP Gillio
Pharmacokinetics and acute toxicology of intraventricular 131 I-monoclonal antibody targeting disialoganglioside in non-human primates.
Journal of neuro-oncology 1997;35(2):101-11.
1997: Nai-Kong V Cheung; Brian H Kushner; Michael P LaQuaglia; Kim Kramer; Peter F Ambros; I Ambros; Marc Ladanyi; J Eddy; M A Bonilla; William Gerald
Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2117-20.
1997: Kim Kramer; Nai-Kong V Cheung; William L Gerald; Michael P LaQuaglia; Brian H Kushner; J M LeClerc; L LeSauter; H Uri Saragovi
Correlation of MYCN amplification, Trk-A and CD44 expression with clinical stage in 250 patients with neuroblastoma.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2098-100.
1997: Kim Kramer; William Gerald; L LeSauteur; H Uri Saragovi; Nai-Kong V Cheung
Monoclonal antibody to human Trk-A: diagnostic and therapeutic potential in neuroblastoma.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2090-1.
1996: Kim Kramer; W Gerald; L LeSauteur; H Uri Saragovi; Nai-Kong V Cheung
Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(8):1361-7.
1995: Kim Kramer; Nai-Kong V Cheung
Autologous bone marrow transplantation in children with advanced neuroblastoma.
Cancer 1995;76(7):1295-7.
1993: Kim Kramer; Brahm Goldstein
Retinal hemorrhages following cardiopulmonary resuscitation.
Clinical pediatrics 1993;32(6):366-8.